184 related articles for article (PubMed ID: 33158741)
1. Disparities in precision medicine-Examining germline genetic counseling and testing patterns among men with prostate cancer.
Borno HT; Odisho AY; Gunn CM; Pankowska M; Rider JR
Urol Oncol; 2021 Apr; 39(4):233.e9-233.e14. PubMed ID: 33158741
[TBL] [Abstract][Full Text] [Related]
2. Racial Differences in Germline Genetic Testing Completion Among Males With Pancreatic, Breast, or Metastatic Prostate Cancers.
Shevach JW; Candelieri-Surette D; Lynch JA; Hubbard RA; Alba PR; Glanz K; Parikh RB; Maxwell KN
J Natl Compr Canc Netw; 2024 Apr; 22(4):237-243. PubMed ID: 38631387
[TBL] [Abstract][Full Text] [Related]
3. Ethnic disparities among men with prostate cancer undergoing germline testing.
Kwon DH; Borno HT; Cheng HH; Zhou AY; Small EJ
Urol Oncol; 2020 Mar; 38(3):80.e1-80.e7. PubMed ID: 31630993
[TBL] [Abstract][Full Text] [Related]
4. Genetic Counseling for Men with Prostate Cancer.
Hyatt C; McDougall C; Miller-Samuel S; Russo J
Urol Clin North Am; 2021 Aug; 48(3):323-337. PubMed ID: 34210488
[TBL] [Abstract][Full Text] [Related]
5. Genetic counseling practices among outpatient obstetric providers in the Northeast.
Peterson JA; Szeto L; Wodoslawsky S; Futterman ID; Silverstein JS; Fiorentino DG; Li D; Al-Kouatly HB; Simpson LL; Roman AS; Strong NK
Am J Obstet Gynecol MFM; 2023 Nov; 5(11):101150. PubMed ID: 37683764
[TBL] [Abstract][Full Text] [Related]
6. Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer.
Cheng HH; Sokolova AO; Gulati R; Bowen D; Knerr SA; Klemfuss N; Grivas P; Hsieh A; Lee JK; Schweizer MT; Yezefski T; Zhou A; Yu EY; Nelson PS; Montgomery B
JCO Precis Oncol; 2023 Jan; 7():e2200104. PubMed ID: 36623239
[TBL] [Abstract][Full Text] [Related]
7. Utilization of genetic testing in men with advanced prostate cancer.
Aguiar JA; Li EV; Siddiqui MR; Soliman MA; Kumar SKSR; Schaeffer EM; Keeter MK; Brown CH; Szymaniak BM; Ross AE
Prostate; 2023 May; 83(6):516-523. PubMed ID: 36591888
[TBL] [Abstract][Full Text] [Related]
8. Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.
Vlaming M; Bleiker EMA; van Oort IM; Kiemeney LALM; Ausems MGEM
BMC Cancer; 2022 Dec; 22(1):1365. PubMed ID: 36581909
[TBL] [Abstract][Full Text] [Related]
9. Racial and Ethnic Disparities in the Use of Prostate Magnetic Resonance Imaging Following an Elevated Prostate-Specific Antigen Test.
Abashidze N; Stecher C; Rosenkrantz AB; Duszak R; Hughes DR
JAMA Netw Open; 2021 Nov; 4(11):e2132388. PubMed ID: 34748010
[TBL] [Abstract][Full Text] [Related]
10. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
[TBL] [Abstract][Full Text] [Related]
11. Health disparities in clinical practice patterns for prostate cancer screening by geographic regions in the United States: a multilevel modeling analysis.
Garg V; Raisch DW; Selig JP; Thompson TA
Prostate Cancer Prostatic Dis; 2013 Jun; 16(2):193-203. PubMed ID: 23399779
[TBL] [Abstract][Full Text] [Related]
12. Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
Paller CJ; Antonarakis ES; Beer TM; Borno HT; Carlo MI; George DJ; Graff JN; Gupta S; Heath EI; Higano CS; McKay RR; Morgans AK; Patnaik A; Petrylak DP; Rettig MB; Ryan CJ; Taplin ME; Whang YE; Vinson J; Cheng HH; Giri VN;
Clin Genitourin Cancer; 2019 Aug; 17(4):275-282.e1. PubMed ID: 31171481
[TBL] [Abstract][Full Text] [Related]
13. Racial and Ethnic Disparities in Germline Genetic Testing of Patients With Young-Onset Colorectal Cancer.
Dharwadkar P; Greenan G; Stoffel EM; Burstein E; Pirzadeh-Miller S; Lahiri S; Mauer C; Singal AG; Murphy CC
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):353-361.e3. PubMed ID: 33359728
[TBL] [Abstract][Full Text] [Related]
14. Racial Disparities in Accessing Care along the Continuum of Cancer Genetic Service Delivery.
Wagner IM; Xuan Z; Lu H; Wang C
Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):55-62. PubMed ID: 37819271
[TBL] [Abstract][Full Text] [Related]
15. Implementation of a Telehealth Genetic Testing Station to Deliver Germline Testing for Men With Prostate Cancer.
Kwon DH; Gordon KM; Tong B; Borno HT; Beigh M; Fattah D; Schleicher A; Aggarwal RR; Blanco AM; Small EJ; Dhawan M
JCO Oncol Pract; 2023 May; 19(5):e773-e783. PubMed ID: 36649492
[TBL] [Abstract][Full Text] [Related]
16. Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.
Loeb S; Cheng HH; Leader A; Gross L; Nolasco TS; Byrne N; Wise DR; Hollifield L; Brown LH; Slater E; Pieczonka C; Gomella LG; Kelly WK; Trabulsi EJ; Handley N; Lallas CD; Chandrasekar T; Mille P; Mann M; Mark JR; Brown G; Chopra S; Wasserman J; Phillips J; Somers P; Giri VN
Contemp Clin Trials; 2022 Aug; 119():106821. PubMed ID: 35710085
[TBL] [Abstract][Full Text] [Related]
17. Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate Cancer.
Abusamra SM; Solorzano MA; Luke M; Quarles J; Jacobs MF; Das S; Kasputis A; Okoth LA; Patel M; Seymore M; Caram MEV; Dunn RL; Merajver SD; Stoffel EM; Reichert ZR; Morgan TM
J Urol; 2022 Nov; 208(5):1007-1017. PubMed ID: 35930793
[TBL] [Abstract][Full Text] [Related]
18. Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling.
Giri VN; Obeid E; Hegarty SE; Gross L; Bealin L; Hyatt C; Fang CY; Leader A
Prostate; 2018 Sep; 78(12):879-888. PubMed ID: 29655297
[TBL] [Abstract][Full Text] [Related]
19. Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants.
Liu YL; Maio A; Kemel Y; Salo-Mullen EE; Sheehan M; Tejada PR; Trottier M; Arnold AG; Fleischut MH; Latham A; Carlo MI; Murciano-Goroff YR; Walsh MF; Mandelker D; Mehta N; Bandlamudi C; Arora K; Zehir A; Berger MF; Solit DB; Aghajanian C; Diaz LA; Robson ME; Brown CL; Offit K; Hamilton JG; Stadler ZK
Cancer; 2022 Nov; 128(21):3870-3879. PubMed ID: 36041233
[TBL] [Abstract][Full Text] [Related]
20. Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma.
Walker EJ; Goldberg D; Gordon KM; Pedley C; Carnevale J; Cinar P; Collisson EA; Tempero MA; Ko AH; Blanco AM; Dhawan M
Oncologist; 2021 Nov; 26(11):e1982-e1991. PubMed ID: 34506673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
